Controlled Electron Transfer: Implementing a Reservoir-Pump-Integrated Strategy to Develop a Type I Photosensitizer for Evoking Long-Term Tumor Immunological Memory
Type I photosensitizers (PSs), due to reduced dependence on O<sub>2</sub>, have outstanding prospects for cancer treatment. However, it is difficult to manipulate electron transfer of molecules during excited state transitions (T<sub>1</sub>-S<sub>0</sub>), which makes it a challenging task to systematically create type I PSs, especially with a deficiency of an instructive molecular construction strategy. Herein, for the first time, we proposed the "electron reservoir-pump-integrated" molecular design strategy, that is, "electron reservoir" and "electron pump" were dexterously fused in one appropriate dye, which greatly facilitated the creation of type I PS molecules through the manipulation of spatial electron flow (verified by the density functional theory and spectral experiments). On this basis, we constructed a series of organic small-molecule type I PSs; especially, the prominent type I PS <b>Cy5-NF</b> could specifically produce a large amount of O<sub>2</sub><sup>•-</sup> under 660 nm laser irradiation. Notably, without the sulfonic acid groups (electron reservoir) or the electron-withdrawing group (electron pump), both derivatives of <b>Cy5-NF</b> are unable to generate O<sub>2</sub><sup>•-</sup>, which fully validated the above strategy. More encouragingly, <b>Cy5-NF</b> could effectively destroy cytomembranes under irradiation and further lead to pyroptosis of tumor cells, which not only ablated the primary/distant tumors but also halted tumor metastasis to the different organs via enhancing CD4<sup>+</sup> and CD8<sup>+</sup> T cell infiltration-mediated long-term immunological memory. Notably, the "electron reservoir-pump-integrated" strategy represents a kind of modular approach for constructing organic small-molecule type I PSs, potentially offering valuable guidance for future type I PS development.
Authors
- Fang Zhu (ORCID: https://orcid.org/0000-0002-6939-9975)
- Mingri Zhao
- Hong‐Wen Liu (ORCID: https://orcid.org/0000-0001-8757-1620)
- Xiaobing Zhang (ORCID: https://orcid.org/0000-0002-4010-0028)
- Li Xu (ORCID: https://orcid.org/0000-0001-9823-8225)
- Zhe Li
- Haifeng Ge
Institutions
- Central South University (CN)
- Hunan University (CN)
- Hunan Normal University (CN)
- Shanghai Jiao Tong University (CN)
- XinHua Hospital (CN)
- Chemo (France) (FR)
- State Key Laboratory of Chemobiosensing and Chemometrics (CN)
Publication Details
- Journal
- Journal of the American Chemical Society
- Published
- 2025-09-21
- DOI
- https://doi.org/10.1021/jacs.5c12631
- Citations
- 2
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 1.35